| 000 | 01669 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513135346.0 | ||
| 264 | 0 | _c19980406 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0887-4476 | ||
| 024 | 7 |
_a10.1002/(SICI)1098-2396(199803)28:3<244::AID-SYN7>3.0.CO;2-A _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaakso, A | |
| 245 | 0 | 0 |
_a[18F]CFT [(18F)WIN 35,428], a radioligand to study the dopamine transporter with PET: characterization in human subjects. _h[electronic resource] |
| 260 |
_bSynapse (New York, N.Y.) _cMar 1998 |
||
| 300 |
_a244-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCarrier Proteins _xphysiology |
| 650 | 0 | 4 |
_aCocaine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
| 650 | 0 | 4 | _aDopamine Uptake Inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorine Radioisotopes _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 |
_aNeostriatum _xchemistry |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xphysiology |
| 650 | 0 | 4 |
_aPresynaptic Terminals _xchemistry |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aTomography, Emission-Computed _xmethods |
| 700 | 1 | _aBergman, J | |
| 700 | 1 | _aHaaparanta, M | |
| 700 | 1 | _aVilkman, H | |
| 700 | 1 | _aSolin, O | |
| 700 | 1 | _aHietala, J | |
| 773 | 0 |
_tSynapse (New York, N.Y.) _gvol. 28 _gno. 3 _gp. 244-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1098-2396(199803)28:3<244::AID-SYN7>3.0.CO;2-A _zAvailable from publisher's website |
| 999 |
_c9456672 _d9456672 |
||